Nichi-Iko Pharmaceutical Co., Ltd. announced consolidated earnings results for the nine months ended December 31, 2018. For the period, the company reported revenue of JPY 127,224 million as compared to JPY 126,017 million for the same period last year. Operating profit was JPY 8,001 million as compare to JPY 7,511 million for the same period last year. Profit was 6,905 million as compared to JPY 6,677 million for the same period last year. Basic net income per share was JPY 118.21 as compared to JPY 118.52 for the same period last year. Diluted net income per share was JPY 116.77 as compared to JPY 118.36 for the same period last year.

For the full year March 31, 2019, the consolidated company expected revenue of JPY 170,000 million, operating profit of JPY 9,500 million, profit attributable to shareholders of the parent company of JPY 7,000 million and basic earnings per share of JPY 117.94.